Restricted accessLetterFirst published online 1995-4
Cytosolic tissue-type plasminogen activator (t-PA) levels in ductal infiltrating carcinomas of the breast classified according to different clinical and biological parameters
NandS.Hemostasis and cancer.Cancer J1993; 6: 54–8.
2.
CrowleyC.W., CohenR.L., LucasB.K., LiuG., ShumanM.A., LevinsonA.D.Prevention of metastasis by inhibition of the urokinase receptor.Proc Natl Acad Sci USA1993; 90: 5021–5.
3.
Grondahl-HansenJ., ChristensenI.J., RosenquisteC.High levels of urokinase-type plasminogen activator and its inhibitor in cytosolic extracts of breast carcinomas are associated with poor prognosis.Cancer Res1993; 53: 2513–21.
4.
JädnickeF., SchmittM., PacheL.Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factor in node negative breast cancer.Breast Cancer Res Treat1993; 24: 195–208.
5.
SchmittM., JädnickeF., GraeffH.Tumor-associated fibrinolysis: the prognostic relevance of plasminogen activators u-PA and t-PA in human breast cancer.Blood Coagulation Fibrinolysis1990, 1: 695–702.
6.
RellaC., CovielloM., QuarantaM., ParadisoA.Tissue-type plasminogen activator as marker of functional steroid receptors in human breast cancer.Thromb Res1993; 64: 209–20.
7.
NeedhanG.K., NicholsonS., AngurB., FarndonJ.R., HarrisA.L.Relationship of membrane bound tissue type and urokinase plasminogen activators in human breast cancer to estrogen and epidermal growth factor receptors.Cancer Res1988; 48: 6603–7.
8.
RuibalA., AlvarezA., Fernández LianaB., Fernández FernándezM., RoisM.C., AllendeM.T.Cytosolic tissue-type plasminogen activator (t-PA) levels in breast tumors and hormone dependance. Role of pS2. Int J Biol Markers (In press).
9.
SumiyoshiK., BabaS., SakaguchiS., UranoT., TakadaY., TakadaA.Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitors in human breast cancer: possible role in tumor prognosis and metastasis.Thromb Res1991; 63: 59–71.
10.
SumiyoshiK., SerizawaK., UranoT., TakadaY., TakadaA., BabaS.Plasminogen activator system in human breast cancer.Int J Cancer1992; 50: 34–8.
11.
DuffyM.J., O'GradyP., DevaneyD., O'SiorainL., FennellyJ.J., LijnenH.R.Tissue-type plasminogen activator, a new prognostic marker in breast cancer.Cancer Res1988, 8: 1348–9.
